|
Valoración de DCF INSMED Incorporated (INSM)
US | Healthcare | Biotechnology | NASDAQ
|
- ✓ Completamente Editable: Adáptelo A Sus Necesidades En Excel O Sheets
- ✓ Diseño Profesional: Plantillas Confiables Y Estándares De La Industria
- ✓ Predeterminadas Para Un Uso Rápido Y Eficiente
- ✓ No Se Necesita Experiencia; Fáciles De Seguir
Insmed Incorporated (INSM) Bundle
¡Descubra el verdadero potencial de Insmed Incorporated (INSM) con nuestra calculadora DCF avanzada! Ajuste los supuestos clave, explore varios escenarios y evalúe cómo los cambios afectan la valoración de InSmed Incorporated (INSM), todo dentro de una plantilla de Excel.
Discounted Cash Flow (DCF) - (USD MM)
| Year | AY1 2019 |
AY2 2020 |
AY3 2021 |
AY4 2022 |
AY5 2023 |
FY1 2024 |
FY2 2025 |
FY3 2026 |
FY4 2027 |
FY5 2028 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 136.5 | 164.4 | 188.5 | 245.4 | 305.2 | 373.6 | 457.4 | 560.0 | 685.5 | 839.3 |
| Revenue Growth, % | 0 | 20.48 | 14.63 | 30.19 | 24.39 | 22.42 | 22.42 | 22.42 | 22.42 | 22.42 |
| EBITDA | -215.7 | -250.4 | -375.1 | -429.4 | -654.7 | -373.6 | -457.4 | -560.0 | -685.5 | -839.3 |
| EBITDA, % | -158.04 | -152.28 | -199.03 | -175.03 | -214.52 | -100 | -100 | -100 | -100 | -100 |
| Depreciation | 10.2 | 20.1 | 27.8 | 24.3 | 10.6 | 35.7 | 43.7 | 53.5 | 65.5 | 80.2 |
| Depreciation, % | 7.46 | 12.21 | 14.78 | 9.89 | 3.47 | 9.56 | 9.56 | 9.56 | 9.56 | 9.56 |
| EBIT | -225.9 | -270.5 | -402.9 | -453.7 | -665.3 | -373.6 | -457.4 | -560.0 | -685.5 | -839.3 |
| EBIT, % | -165.5 | -164.5 | -213.81 | -184.92 | -217.99 | -100 | -100 | -100 | -100 | -100 |
| Total Cash | 487.4 | 532.8 | 716.8 | 1,148.3 | 780.4 | 373.6 | 457.4 | 560.0 | 685.5 | 839.3 |
| Total Cash, percent | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Account Receivables | 19.2 | 16.6 | 24.4 | 29.7 | 41.2 | 46.8 | 57.4 | 70.2 | 86.0 | 105.2 |
| Account Receivables, % | 14.09 | 10.07 | 12.92 | 12.11 | 13.5 | 12.54 | 12.54 | 12.54 | 12.54 | 12.54 |
| Inventories | 28.3 | 49.6 | 67.0 | 69.9 | 83.2 | 106.3 | 130.1 | 159.3 | 195.0 | 238.8 |
| Inventories, % | 20.75 | 30.16 | 35.56 | 28.5 | 27.28 | 28.45 | 28.45 | 28.45 | 28.45 | 28.45 |
| Accounts Payable | 13.2 | 42.9 | 35.8 | 50.5 | 65.4 | 72.3 | 88.5 | 108.3 | 132.6 | 162.3 |
| Accounts Payable, % | 9.66 | 26.06 | 18.99 | 20.57 | 21.43 | 19.34 | 19.34 | 19.34 | 19.34 | 19.34 |
| Capital Expenditure | -42.3 | -6.8 | -7.3 | -9.9 | -13.3 | -35.4 | -43.3 | -53.1 | -64.9 | -79.5 |
| Capital Expenditure, % | -30.97 | -4.15 | -3.87 | -4.03 | -4.35 | -9.47 | -9.47 | -9.47 | -9.47 | -9.47 |
| Tax Rate, % | -0.34203 | -0.34203 | -0.34203 | -0.34203 | -0.34203 | -0.34203 | -0.34203 | -0.34203 | -0.34203 | -0.34203 |
| EBITAT | -226.5 | -271.7 | -401.3 | -455.0 | -667.6 | -373.3 | -457.1 | -559.5 | -685.0 | -838.6 |
| Depreciation | ||||||||||
| Changes in Account Receivables | ||||||||||
| Changes in Inventories | ||||||||||
| Changes in Accounts Payable | ||||||||||
| Capital Expenditure | ||||||||||
| UFCF | -293.0 | -247.4 | -413.0 | -434.2 | -680.2 | -394.8 | -474.8 | -581.2 | -711.6 | -871.1 |
| WACC, % | 9.41 | 9.41 | 9.41 | 9.41 | 9.41 | 9.41 | 9.41 | 9.41 | 9.41 | 9.41 |
| PV UFCF | ||||||||||
| SUM PV UFCF | -2,253.4 | |||||||||
| Long Term Growth Rate, % | 2.00 | |||||||||
| Free cash flow (T + 1) | -889 | |||||||||
| Terminal Value | -11,988 | |||||||||
| Present Terminal Value | -7,645 | |||||||||
| Enterprise Value | -9,899 | |||||||||
| Net Debt | 722 | |||||||||
| Equity Value | -10,620 | |||||||||
| Diluted Shares Outstanding, MM | 140 | |||||||||
| Equity Value Per Share | -75.63 |
What You Will Receive
- Flexible Forecast Inputs: Effortlessly modify assumptions (growth %, margins, WACC) to explore various scenarios.
- Real-World Data: Insmed Incorporated’s financial data pre-loaded to facilitate your analysis.
- Automated DCF Outputs: The template computes Net Present Value (NPV) and intrinsic value automatically for you.
- Customizable and Professional: A refined Excel model that adjusts to your valuation requirements.
- Designed for Analysts and Investors: Perfect for evaluating projections, confirming strategies, and enhancing efficiency.
Key Features
- Comprehensive Financial Insights: Gain access to precise historical data and future forecasts for Insmed Incorporated (INSM).
- Tailored Projection Inputs: Modify highlighted fields such as WACC, growth rates, and profit margins to suit your analysis.
- Real-Time Calculations: Experience automatic updates for DCF, Net Present Value (NPV), and cash flow evaluations.
- Interactive Dashboard: Utilize intuitive charts and summaries to effectively visualize your valuation outcomes.
- Designed for All Users: A user-friendly layout catered to investors, CFOs, and consultants alike.
How It Works
- Download: Obtain the pre-built Excel file containing Insmed Incorporated’s (INSM) financial data.
- Customize: Modify assumptions, such as revenue projections, EBITDA %, and WACC.
- Update Automatically: The intrinsic value and NPV calculations refresh in real-time.
- Test Scenarios: Generate various forecasts and analyze results instantly.
- Make Decisions: Leverage the valuation insights to inform your investment choices.
Why Choose This Calculator for Insmed Incorporated (INSM)?
- Designed for Experts: A specialized tool utilized by investment analysts, CFOs, and healthcare consultants.
- Accurate Financial Data: Insmed’s historical and projected financials are preloaded for precise calculations.
- Flexible Scenario Analysis: Effortlessly simulate various forecasts and assumptions.
- Comprehensive Outputs: Automatically calculates intrinsic value, NPV, and essential financial metrics.
- User-Friendly Interface: Step-by-step guidance ensures a smooth calculation experience.
Who Should Use This Product?
- Professional Investors: Develop comprehensive and accurate valuation models for assessing investments in Insmed Incorporated (INSM).
- Corporate Finance Teams: Evaluate valuation scenarios to inform strategic decisions within their organizations.
- Consultants and Advisors: Deliver precise valuation insights to clients interested in Insmed Incorporated (INSM) stock.
- Students and Educators: Utilize real-time data to enhance learning and practice in financial modeling related to Insmed Incorporated (INSM).
- Healthcare Enthusiasts: Gain insights into how biotech companies like Insmed Incorporated (INSM) are valued in the financial markets.
What the Template Contains
- Pre-Filled Data: Contains Insmed Incorporated's historical financials and projections.
- Discounted Cash Flow Model: Editable DCF valuation model with real-time calculations.
- Weighted Average Cost of Capital (WACC): A dedicated sheet for calculating WACC based on user-defined inputs.
- Key Financial Ratios: Assess Insmed's profitability, efficiency, and financial leverage.
- Customizable Inputs: Easily modify revenue growth, profit margins, and tax rates.
- Clear Dashboard: Visual representations and tables summarizing essential valuation outcomes.